HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma
Journal of Gastroenterology · 2026-08 · 61 (8) · 1146-1158
DOI: 10.1007/s00535-026-02433-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology, online erschienen am 30.04.2026. Verfasst von Masatake Kanai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, 162-8655…. Hauptthemen laut MEDLINE: MicroRNAs, Carcinoma, Hepatocellular, Liver Neoplasms, Fibrinogen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Agency for Medical Research and Development, National Center for Global Health and Medicine Intramural Research Fund, Japan Institute for Health Security.
Abstract (Originalsprache)
Background
Hepatitis B virus (HBV) infection remains a leading cause of hepatocellular carcinoma (HCC), yet the molecular mechanisms underlying HBV-mediated hepatocarcinogenesis are not fully understood. This study focused on miR-4461, which is encoded within the intronic region of PCBD2 gene, and investigated its role in HBV-derived HCC. Methods miR-4461 expression was examined in HBV-expressing hepatoma cell lines and in HBV-infected primary human hepatocytes. Functional analysis evaluated the effects of miR-4461 overexpression or inhibition on hepatocyte proliferation. Candidate targets were screened, and fibrinogen alpha chain (FGA) was tested for regulation by miR-4461. Circulating miR-4461 and plasma FGA were measured in patients with chronic viral hepatitis, including those with HBV-related HCC; in the HBV-HCC cohort, FGA was also assessed before and after surgical tumor resection. Results miR-4461 expression was significantly reduced in HBV-expressing hepatoma cells and HBV-infected primary hepatocytes. Overexpression of miR-4461 inhibited hepatocyte proliferation, whereas its inhibition enhanced proliferation, indicating a tumor-suppressive function. FGA was identified as a downstream target; in hepatoma cells, FGA protein levels were regulated by miR-4461. Clinically, circulating miR-4461 levels were significantly lower in HBV-infected individuals, particularly in those with HBV-related HCC. In contrast, plasma FGA protein levels were markedly elevated in HBV-related HCC and decreased significantly after tumor resection.
Conclusions
These findings suggest a novel regulatory axis in HBV-associated HCC involving HBV-induced suppression of miR-4461 and subsequent upregulation of FGA. Both miR-4461 and FGA were associated with disease status, supporting their potential utility as biomarkers or therapeutic targets in HBV-derived HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, 162-8655, Japan.
- Faculty of Life Sciences, Tokyo University of Agriculture, Tokyo, Japan.
- Department of Gastroenterology and Hepatology, National Kohnodai Medical Center, Japan Institute for Health Security, Chiba, Japan.
- Department of Surgery, National Center for Global Health and Medicine, Japan Institute for Health Security, Tokyo, Japan.
- Department of Hepato-Biliary-Pancreatic Surgery and Pediatric Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
- Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health Security, Tokyo, 162-8655, Japan. sugiyama.m@jihs.go.jp.
ORCID-Profile: Masaya Sugiyama
Förderung
- Japan Agency for Medical Research and Development
- National Center for Global Health and Medicine Intramural Research Fund
- Japan Institute for Health Security
Zitieren
APA
Kanai, M., Sakai, A., Date, T., Aoki, Y., Mihara, F., Kokudo, T., Inagaki, F., Takemura, N., Kokudo, N., & Sugiyama, M. (2026). HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma. Journal of Gastroenterology, 61(8), 1146-1158. https://doi.org/10.1007/s00535-026-02433-1
Vancouver
Kanai M, Sakai A, Date T, Aoki Y, Mihara F, Kokudo T, et al. HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma. Journal of Gastroenterology. 2026;61(8):1146-1158. doi:10.1007/s00535-026-02433-1
BibTeX
@article{Kanai2026,
author = {Kanai, Masatake and Sakai, Aiko and Date, Tomoko and Aoki, Yoshihiko and Mihara, Fuminori and Kokudo, Takashi and Inagaki, Fuyuki and Takemura, Nobuyuki and Kokudo, Norihiro and Sugiyama, Masaya},
title = {HBV-induced miR-4461 downregulation correlates with elevated fibrinogen alpha chain expression in hepatocellular carcinoma},
journal = {Journal of Gastroenterology},
year = {2026},
volume = {61},
number = {8},
pages = {1146--1158},
doi = {10.1007/s00535-026-02433-1}
}
EUVIMED